HedgeChatter

  • Home /
  • Tag Archives

MNOV

MEDICINOVA INC Files SEC form 10-K, Annual Report

moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboardSee who MediciNova is hiring next, click here to view […]

March 28, 2013 Bystocknews , Comments Off on MEDICINOVA INC Files SEC form 10-K, Annual Report read more

FDA Grants Fast Track Designation for MediciNova’s MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence

[at noodls] – FDA Grants Fast Track Designation for MediciNova’s MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence SAN DIEGO, Feb. 25, 2013 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical … moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboardSee who MediciNova is hiring next, click here to view […]

February 25, 2013 Bystocknews , Comments Off on FDA Grants Fast Track Designation for MediciNova’s MN-166 (ibudilast) for the Treatment of Methamphetamine Dependence read more

MediciNova Provides Development Update

[at noodls] – Company Finalizing Development Plans for MN-221 While Enhancing MN-166 Program SAN DIEGO, Jan. 3, 2013 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ … moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboardSee who MediciNova is hiring next, click here to view […]

January 3, 2013 Bystocknews , Comments Off on MediciNova Provides Development Update read more

MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma

[at noodls] – SAN DIEGO, Dec. 9, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities … moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboardSee who MediciNova is hiring next, click here to […]

December 10, 2012 Bystocknews , Comments Off on MediciNova Receives Notice of Patent Allowance for Method of Treating Acute Exacerbations of Asthma read more

MediciNova to Present at the Lazard Capital Markets Healthcare Conference

[at noodls] – SAN DIEGO, Nov. 7, 2012 (GLOBE NEWSWIRE) — MediciNova Inc, a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: … moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboard […]

November 7, 2012 Bystocknews , Comments Off on MediciNova to Present at the Lazard Capital Markets Healthcare Conference read more

MediciNova Meets With FDA for End-of-Phase 2 Meeting for MN-221 for the Treatment of Acute Exacerbations of Asthma

[at noodls] – MediciNova Meets With FDA for End-of-Phase 2 Meeting for MN-221 for the Treatment of Acute Exacerbations of Asthma SAN DIEGO, Oct. 22, 2012 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company … moreView todays social media effects on MNOVView the latest stocks trending across Twitter. Click to view dashboard […]

October 22, 2012 Bystocknews , Comments Off on MediciNova Meets With FDA for End-of-Phase 2 Meeting for MN-221 for the Treatment of Acute Exacerbations of Asthma read more